The global market research antibodies market was valued at USD 2.5 billion in 2022 and is projected to reach USD 5.1 billion by 2032, with a revenue compound annual growth rate (CAGR) of 8.1% during the forecast period. The increasing demand for personalized treatment, the rising incidence of cancer and infectious diseases, and the growing focus on research and development activities in the pharmaceutical and biotechnology industries are the primary drivers behind the revenue growth in the market.
https://www.reportsanddata.com..../report-detail/resea
Харесвам
Коментирай
Сподели
